Aadi Bioscience, Inc.
Aadi Bioscience, Inc.（AADI）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
aadi · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年3月26日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$1.75
Consensus
$1.63
-4.7% upside
Low
$1.50
Median: $1.625 · Last Close: $1.71
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$1.63
-4.7% upside
High Target
$1.75
2.3%
Low Target
$1.5
-12.3%
Current Price
$1.71
as of today
Based on analyst price targets, the AADI stock price prediction for the next 12 months ranges from $1.5 to $1.75. The consensus AADI price forecast of $1.63 implies -4.7% upside from the current price of $1.71.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.62 | ↓ 5.00% |
1-day model range: $1.6–$1.65. Peak: $1.65 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · AADI · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-08-27 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2024-08-21 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2024-08-21 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2023-12-15 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-12-15 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-06-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Aadi Bioscience, Inc. (AADI) stock. Of the recent 25 rating actions, 0 were upgrades and 3 were downgrades. 6 analysts currently cover AADI.
分析师推荐趋势
AADI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$14M
↓ 58.7% YoY
Revenue Next Year
$15M
↑ 7.9% YoY
EPS This Year
$-0.51
EPS Next Year
$-0.95
↑ 86.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast AADI EPS of $-0.51 for the current fiscal year, based on estimates from 2 analysts. The AADI revenue forecast is $14M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AADI 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AADI 的共识目标价为 $1.63（-4.7% 上行空间），分析师共识为 Buy。
AADI 的短期预测（明日）为 $1.62（-5.00%）。
Aadi Bioscience, Inc. 在 NASDAQ 上市，代码 AADI。AADI 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。
常见问题
AADI 预测 · 8 个问题根据 6 位华尔街分析师，AADI 的 12 个月平均目标价为 $1.63，最高 $1.75、最低 $1.50。若有图表，中位目标价可在上方查看。相对当前价 $1.71，隐含约 -4.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.